A Dem Donor's Family Member Summed Up a Meeting With Biden in Two...
The Biden Administration's Last Hurrah in Incompetence Occurs in the Red Sea
A 'Missing' GOP Rep Has Been Found...and It's Not a Good Situation
Joy to the World
Senate Dems Celebrate Just Barely Surpassing Trump on Judicial Confirmations
A Quick Bible Study Vol. 247: Advent and Christmas Reflection - Seven Lessons
The Expanding Culture Of Death And How To Stop It
Report: Biden's Nap Delayed Meeting With Gold Star Families Following Chaotic Afghanistan...
Scranton Officials Demand for Biden’s Name to Be Removed from Landmark
Why Hasn’t NASA Told Us About This?
Biden Staffers Pressuring President to Dole Out Millions to Defund the Police
What's Next for Lara Trump?
Biden Admin Funded $4 Million Program to Pull Kids Out of School and...
Did the U.S. Government Orchestrate Regime Change In Syria? Thomas Massie Thinks So.
O Come, O Come, Emmanuel, and Ransom Captive Israel
Tipsheet

Moderna Announces Development of Combination COVID-19 Booster and Flu Vaccine

AP Photo/Rogelio D. Solis

Moderna announced on Thursday it had begun development for a potential single-dose vaccine that is a combination of a Wuhan coronavirus vaccine booster shot and seasonal flu shot. 

Advertisement

In a press release published Thursday, Moderna CEO Stephane Bancel announced the new development and shared the progress of other programs the company is working on, such as their “cancer vaccine.” 

“Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19 and a booster against flu,” Bancel said in a statement. “We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalized cancer vaccine trial. We believe this is just the beginning of a new age of information-based medicines.”

As we previously reported, Moderna informed investors and analysts last month that the company was planning for a booster COVID-19 shot in addition to its already-existing two-dose mRNA vaccine shot. As of right now, the Moderna COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) to be administered to prevent the spread of COVID-19. However, the vaccine has not been fully approved by the FDA.

Advertisement

“We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months, but recognize that the Delta variant is a significant new threat so we must remain vigilant,” Bancel said in a statement last month announcing plans for a potential booster shot. In the statement, Bancel also said Moderna is “looking forward towards our vision of a single dose annual booster that provides protection against COVID-19, flu and RSV for adults.”

Perhaps that vision could be on the horizon with this hybrid coronavirus/flu vaccine in the works. This week, however, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus reiterated his call for a halt on COVID-19 booster shots through the end of the year. Moderna has not revealed when it plans to have the booster shot completed.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement